Table 3 Baseline Clinical and Laboratory investigation results of the patients before treatment
Parameters | All Subjects | Renal replacement therapy group | Conservative group | P value |
|---|---|---|---|---|
mean ± SD/ Median [IQR] | Mean ± SD/Median [IQR] | mean ± SD/Median [IQR] | ||
SBP (mmHg) | 154.85 ± 25.1 | 152.6 ± 25.3 | 155.3 ± 25.1 | 0.459 |
DBP (mmHg) | 90.0 [79.0-100.0] | 83.3 [78.3–93.8] | 90.0 [79.3-100.1] | 0.047 |
Haemoglobin | 8.0 [6.9–9.2] | 8.3 [7.2–9.1] | 7.9 [6.8–9.2] | 0.309 |
White Blood Count | 5.6 [4.6–7.1] | 5.8 [5.0-7.2] | 5.6 [4.5–7.1] | 0.136 |
MCV | 82.6 ± 6.8 | 83.11 ± 6.4 | 82.5 ± 6.9 | 0.557 |
MCH | 27.67 ± 2.6 | 27.7 ± 2.6 | 27.7 ± 2.6 | 0.858 |
Sodium | 135.7 [132.6–138.0] | 136.0 [136.0-139.0] | 135.5 [131.6–138.0] | 0.159 |
Potassium | 5.0 [4.5–5.6] | 4.9 [4.0-5.4] | 5.1 [4.5–5.6] | 0.093 |
Urea | 28.0 [20.0-37.4] | 22.2 [15.0-30.3] | 28.6 [20.9–38.0] | 0.001 |
Triglycerides | 1.3 [1.0-1.8] | 1.2 [1.0-1.5] | 1.3 [1.0–2.0] | 0.566 |
LDL-c | 3.1 [2.2–3.8] | 2.9 [2.0-4.1] | 3.1 [2.3–3.8] | 0.809 |
HDL-c | 1.2 [0.8–1.5] | 1.2 [0.8–1.6] | 1.1 [0.8–1.4] | 0.945 |
VLDL-c | 0.6 [0.4-1.0] | 0.6 [0.4–0.8] | 0.6 [0.5–1.1] | 0.368 |
Cholesterol | 5.0 [3.9–5.8] | 5.0 [3.6–6.1] | 5.0 [4.0-5.8] | 0.593 |
Creatinine | 1095.0 [703.4-1581.5] | 1004.5 [570.8-1678.8] | 1116.9 [714.0-1563.0] | 0.333 |
eGFR | 4.0 [3.0–7.0] | 5.0 [3.0-8.3] | 4.0 [3.0–7.0] | 0.433 |
Positive | N (%) | N (%) | N (%) | |
Urine Protein | 187(92.1) | 27(93.1) | 160(92.0) | < 0.001 |
Urine Blood | 105(55.6) | 12(50.0) | 93(56.4) | < 0.001 |